Breast Pathology Treatment and Drugs

Breast cancer treatment team mainly includes Breast surgeon, surgical oncologist, radiation oncologist, medical oncologist, plastic surgeon. It also includes a variety of other health care professionals, including physician assistants, oncology nurses, social workers, pharmacists, counsellors, nutritionists, and others. The biology and behaviour of a breast cancer affects the treatment plan. Treatment options and recommendations are very personalized and depend on several factors, including: stage of tumour, tumour subtypes, genomic maker, patient age, and patient menopausal status, mutations in inherited breast cancer genes, such as BRCA1 or BRCA2. For both DCIS and early-stage invasive breast cancer, doctors generally perform surgery to remove the tumour. For larger cancers, or those that are growing more quickly, doctors may recommend systemic treatment with chemotherapy or hormonal therapy before surgery, called neoadjuvant therapy.

    Related Conference of Breast Pathology Treatment and Drugs

    February 04-05, 2021

    5th Annual Summit on Rare Diseases and Orphan Drugs

    Bangkok, Thailand
    February 25-26, 2021

    4th World Congress on Pathology and Clinical Practice

    Vienna, Austria
    March 24-25, 2021

    3rd Pathology and Infectious Disease Conference

    Paris, France
    April 08-09, 2021

    17th Global Experts Meeting on Pathology and Laboratory Medicine

    Port Moresby, New Guinea
    April 12-13, 2021

    18th Asia Pacific Pathology Congress

    Tokyo, Japan
    October 19-20, 2021

    Global pathologists meet

    Manila, Philippines
    October 19-20, 2021

    World Congress on Pathology and Microbiology

    Angeles, Philippines

    Breast Pathology Treatment and Drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in